Dermatol. praxi. 2023;17(4):212-218 | DOI: 10.36290/der.2023.038

Steatocystoma multiplex successfully treated with peroral isotretinoin - a casuistics

MUDr. Zuzana Nevoralová, Ph.D.
Akné poradna, Nemocnice Jihlava, p. o.

A casuistics of a 30-year-old man who was sent to our Acne Clinic because of skin problems lasting for about 8 years is presented. Objectivelly, on the face, neck and trunk many arches were present, the biggest one under the left eyebrow and under the right ear. There were some comedones, papules and small nodules on the trunk. Histological examination of a cyst under the right ear revealed a diagnosis of steatocystoma. Because of concomitant diagnoses acne nodulocystica and steatocystoma multiplex, a treatment with peroral isotretinoin was started with an initial dose 0,25 mg/kg/day, after one month the dose was increased to 0,40 mg/kg/day. Acne was cleared within 6 months. Because of steatocystoma multiplex, the treatment with peroral isotretinoin has been continued. After 20 months of the treatment, the dose of isotretinoin was decreased step by step to a dose 0,075 mg/kg/den (10 mg 4× weekly). The treatment is very well tolerated. For the whole time, local adapalen cream in the evening is applied. In the meantime, the biggest cyst under the left eyebrow was excised with a very good cosmetic result. Cysts on the face, neck and trunk have been slowly diminishing, some have disappeared . Because of steatocystoma multiplex is a chronic disease, a long- term treatment with a low- dose of peroral isotretinoin under regular check-ups has been planned. The patient is very satisfied with the treatment´s effect.

Keywords: steatocystoma multiplex, acne, isotretinoin, long-term treatment.

Accepted: November 15, 2023; Published: November 21, 2023  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Nevoralová Z. Steatocystoma multiplex successfully treated with peroral isotretinoin - a casuistics. Dermatol. praxi. 2023;17(4):212-218. doi: 10.36290/der.2023.038.
Download citation

References

  1. Kamra HT, Gadgil PA, Ovhal AG, et al. Steatocystoma multiplex-a rare genetic disorder: a case report and review of the literature. J Clin Diagn Res. 2013;7:166-168. Go to original source... Go to PubMed...
  2. Lima AM, Batista CMA, Rocha SP, et al. Esteatocistoma múltiplo. An Bras Dermatol. 2011;86:165-166. Go to original source...
  3. Cho S, Chang SE, Choi JH, et al. Clinical and histologic features of 64 cases of steatocystoma multiplex. J Dermatol. 2002;29:152-156. Go to original source... Go to PubMed...
  4. Varshney M, Aziz M, Maheshwari V, et al. Steatocystoma multiplex. BMJ Case Rep. 2011;2011:bcr0420114165. Go to original source... Go to PubMed...
  5. Gordon Spratt EA, Kaplan J, Patel RR, et al. Steatocystoma. Dermatol Online J. 2013;19:20721-20721. Go to original source...
  6. Fekete GL, Fekete JE. Steatocystoma multiplex generalisata partially suppurativa-case report. Acta Dermatovenerol Croat. 2010;18:114-119.
  7. Kim SJ, Park HJ, Oh ST, et al. A case of steatocystoma multiplex limited to scalp. Ann Dermatol. 2009;21:106-109. Go to original source... Go to PubMed...
  8. Ha WW, Wang J, Wang W, et al. A novel missense mutation of keratin 17 gene in a chinese family with steatocystoma multiplex. Ann Dermatol. 2013;25:508-510. Go to original source... Go to PubMed...
  9. Alsabbagh MM: Steatocystoma multiplex: a review. J Dermatol Dermatol Surg 2016;20:91-99. Go to original source...
  10. Plewig G, Kligman AM. Steatocystoma multiplex. In: Plewig G, Kligman AM Akne und Rosazea. Springer, Berlin, Heidelberg. 1994. https://doi.org/10.1007/978-3-642-57960-8_47. Go to original source...
  11. Apaydin R, Bilen N, Bayramgürler D, et al. Steatocystoma multiplex suppurativum: oral isotretinoin treatment combined with cryotherapy. Australas J Dermatol. 2000;41:98-100. Go to original source... Go to PubMed...
  12. Fletcher J, Posso-De Los Rios C, Jambrosic J, et al. Coexistence of Hidradenitis Suppurativa and Steatocystoma Multiplex: Is It a New Variant of Hidradenitis Suppurativa? J Cut Medicine and Surgery 2021;25(6):586-559. Go to original source... Go to PubMed...
  13. Mahmood M, Sabbagh A. Steatocystoma multiplex: a review. J Dermatol Dermatol Surg 2016; 20:91-99. Go to original source...
  14. Braun-Falco M. Steatocystoma multiplex. In: Braun-Falco´s Dermatology, Springer Medizin Verlag. 2009;(3): 1332-1333. Go to original source...
  15. Holmes R, Black MM. Steatocystoma multiplex with unusual prominent cysts on the face. Br J Dermatol. 1980;102: 711-713. Go to original source... Go to PubMed...
  16. Rosen BL, Brodkin RH. Isotretinoin in the treatment of steatocystoma multiplex: A possible adverse reaction. Cutis. 1986;40:115-120.
  17. Hanson N, Leachman S: Safety Issues in Isotretinoin Therapy. Semin Cutan Med Surg. 217. 2001;20(3):166-183. doi: 10.1053/sder.2001.28209. Go to original source... Go to PubMed...
  18. Statham BN, Cunliffe WJ. Treatment of steatocystoma multiplex suppurativum with isotretinoin. Br J Dermatol. 1984;111:246. Go to original source... Go to PubMed...
  19. Moritz DL, Silverman RA. Steatocystoma multiplex treated with isotretinoin: a delayed response. Cutis. 1988;42(5):437-439.




Dermatology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.